Premium
COMBINATORIAL SCREENING OF THE PI3K INHIBITOR COPANLISIB IN T CELL LYMPHOMAS
Author(s) -
Gaudio E.,
Kwee I.,
Spriano F.,
Tarantelli C.,
Rinaldi A.,
Jourdan T.,
Berthold M.,
Arribas A.,
Stathis A.,
Rossi D.,
Liu N.,
Lange M.,
Politz O.,
Zucca E.,
Bertoni F.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_122
Subject(s) - romidepsin , brentuximab vedotin , bortezomib , anaplastic large cell lymphoma , medicine , cancer research , bendamustine , panobinostat , palbociclib , venetoclax , pharmacology , lymphoma , chemistry , cancer , multiple myeloma , immunology , cd30 , breast cancer , leukemia , chronic lymphocytic leukemia , histone deacetylase , gene , histone , rituximab , metastatic breast cancer , biochemistry